Question 1

What is the analyst consensus rating for RAPT?

Accepted Answer

The analyst consensus rating for RAPT is "Hold" based on 6 analyst recommendations.

Question 2

What is the average price target for RAPT?

Accepted Answer

The average 12-month price target for RAPT is $58.00, representing an upside of 0.3% from the current price of $57.84.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Jan 21, 2026	Thomas Smith	Leerink Partners	Downgrades	Hold	$58.00
Jan 21, 2026	Etzer Darout	Barclays	Downgrades	Hold	$58.00
Jan 20, 2026	Kaveri Pohlman	Clear Street	Downgrades	Hold	$60.00 → $58.00 -2.00 (-3.3%)
Jan 20, 2026	Emily Bodnar	HC Wainwright	Downgrades	Hold	$58.00
Jan 20, 2026	Yaron Werber	TD Cowen	Downgrades	Hold	-
Jan 20, 2026	Yanan Zhu	Wells Fargo	Downgrades	Hold	$58.00
Dec 18, 2025	Yaron Werber	TD Cowen	Initiates	Strong Buy	-

RAPT Therapeutics (RAPT) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest RAPT Analyst Ratings & Recommendations